Drug Shortage Report for DIASTAT
Report ID | 159254 |
Drug Identification Number | 02238162 |
Brand name | DIASTAT |
Common or Proper name | DIASTAT |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | DIAZEPAM |
Strength(s) | 5MG |
Dosage form(s) | GEL |
Route of administration | RECTAL RECTAL |
Packaging size | 5mg/2pk |
ATC code | N05BA |
ATC description | ANXIOLYTICS |
Reason for shortage | Shortage of an inactive ingredient or component. |
Anticipated start date | 2022-04-25 |
Actual start date | 2022-04-22 |
Estimated end date | 2022-11-30 |
Actual end date | 2022-11-22 |
Shortage status | Resolved |
Updated date | 2022-11-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2022-11-23 | French | Compare |
v13 | 2022-11-23 | English | Compare |
v12 | 2022-10-05 | French | Compare |
v10 | 2022-10-05 | English | Compare |
v11 | 2022-10-05 | English | Compare |
v9 | 2022-07-20 | French | Compare |
v8 | 2022-07-20 | English | Compare |
v7 | 2022-05-26 | French | Compare |
v6 | 2022-05-26 | English | Compare |
v5 | 2022-04-28 | French | Compare |
v4 | 2022-04-28 | English | Compare |
v3 | 2022-04-26 | English | Compare |
v2 | 2022-04-21 | French | Compare |
v1 | 2022-04-21 | English | Compare |
Showing 1 to 14 of 14